Veterinary Medicines

Nafpenzal dc, suspensão intramamária para bovinos e ovinos

Not authorised
  • Dihydrostreptomycin
  • Benzylpenicillin procaine
  • Nafcillin
Download as PDF

Product identification

Medicine name:
Nafpenzal dc, suspensão intramamária para bovinos e ovinos
Active substance:
  • Dihydrostreptomycin
  • Benzylpenicillin procaine
  • Nafcillin
Target species:
  • Cattle (dairy cow at drying-off)
  • Sheep (dry ewe)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Dihydrostreptomycin
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    Syringe
  • Nafcillin
    100.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dairy cow at drying-off)
      • Meat and offal
        16
        day
      • Milk
        42
        day
    • Sheep (dry ewe)
      • Meat and offal
        28
        day
      • Milk
        3
        month
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Revoked
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • MSD Animal Health Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 1248/01/19NFVPT
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 29/05/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."